Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Choosing the right passive funds can reduce costs and improve retirement outcomes. Explore Which Passive Funds Are Best Value For Retirement to find efficient options.
26,439 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Analysts lift HIMS, TDOC, and ALEC as strategic partnerships reduce key risks, prompting renewed upside potential and...
Bitcoin's long-term holder realized supply remains elevated near peak levels even as prices pause. Analysts say the c...
Crypto advocates urge the Senate Banking Committee to protect DeFi protections and stablecoin rewards as hearings app...
Clayton launches the TRU Mini Home Collection, sub-900 square feet, built for narrow lots and smaller parcels. The mo...
TJX shattered a retail milestone by exceeding $60 billion in annual revenue for the first time, signaling enduring st...
Netflix announces a second price increase in two years, boosting monthly costs for ad-supported and standard/premium ...
Investors are watching novavax (nvax) 2025 earnings closely as the company pivots its vaccine portfolio. This article...
Strategy adds 535 BTC for roughly $43 million, expanding a monumental on-balance-asset position. The total stake now ...
As 2026 unfolds, Resideo's earnings trajectory blends hardware sales with growing recurring revenue. This guide break...
As AI demand accelerates, Nvidia stands out on a growth-adjusted valuation. Cramer argues the stock is cheaper than p...
A Dallas-based brokerage joins Compass, expanding its footprint across Dallas–Fort Worth and Austin with a team of 10...